What follow-up tests do I need after Liver Cancer treatment ends
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Follow-Up Testing After Liver Cancer Treatment
Great question—surveillance after treatment is a critical part of your care plan. According to the NCCN Guidelines for Hepatocellular Carcinoma (HCC), here's what you should expect:
Standard Surveillance Schedule
For the first 2 years after treatment:
- Imaging every 3-6 months (multiphasic CT or MRI of your abdomen)
- AFP blood test every 3-6 months (AFP is a tumor marker—a protein that can indicate cancer activity)
After 2 years:
- Imaging every 6 months
- AFP testing every 6 months
Long-term (5+ years):
- Surveillance should continue for at least 5 years
- After that, your doctor will determine ongoing screening based on your individual risk factors
Why These Tests Matter
Imaging (CT/MRI): These scans look for signs of cancer recurrence in your liver or spread to other areas. The scans use contrast dye to highlight any suspicious areas.
AFP Testing: This blood test measures alpha-fetoprotein levels. While not specific to cancer alone, rising AFP levels combined with imaging findings can suggest HCC recurrence.
Important Considerations for Your Situation
According to NCCN Guidelines, your specific follow-up plan depends on:
- Your liver function (assessed through tests like bilirubin, albumin, and INR—measures of how well your liver is working)
- Whether you had resection, transplant, or locoregional therapy (ablation, chemoembolization, radiation)
- Your underlying liver disease (hepatitis B or C status)
Questions to Ask Your Oncology Team
- Which imaging method is best for me—ultrasound, CT, or MRI? (Each has different strengths)
- What specific AFP level would be concerning, and how do you interpret my results?
- How long will I need surveillance, and when can we potentially reduce frequency?
- Should I be screened for other conditions related to my liver disease (like portal hypertension or varices)?
- Are there any clinical trials I should know about if recurrence is detected?
Additional Monitoring
Beyond imaging and AFP, your doctor will likely monitor:
- Liver function tests (bilirubin, transaminases, alkaline phosphatase)
- Blood counts (platelets, hemoglobin)
- Kidney function (creatinine, BUN)
- Clotting ability (INR/prothrombin time)
These help assess how well your remaining liver is functioning and catch any complications early.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Liver Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with treatment for Liver Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: